vs
Ginkgo Bioworks Holdings, Inc.（DNA）与FGI Industries Ltd.（FGI）财务数据对比。点击上方公司名可切换其他公司
Ginkgo Bioworks Holdings, Inc.的季度营收约是FGI Industries Ltd.的1.1倍（$33.4M vs $30.5M），FGI Industries Ltd.同比增速更快（-14.4% vs -23.8%），FGI Industries Ltd.自由现金流更多（$2.3M vs $-47.7M），过去两年FGI Industries Ltd.的营收复合增速更高（-0.5% vs -6.2%）
Ginkgo Bioworks Holdings, Inc.是一家2008年由五名麻省理工学院科学家创立的美国生物技术企业，由杰森·凯利掌舵。公司专注于基因工程改造，为其他生物科技企业开发具备工业应用价值的菌株，帮助合作方省去合成生物学设计初期的重复研发成本，号称「生物制造平台企业」，2019年估值就已达42亿美元。
FGI Industries Ltd是一家全球厨卫产品、家居收纳解决方案及家装用品的设计、制造与分销商，服务覆盖北美、欧洲及亚太地区的大型连锁零售商、家居专营店和电商平台。
DNA vs FGI — 直观对比
营收规模更大
DNA
是对方的1.1倍
$30.5M
营收增速更快
FGI
高出9.4%
-23.8%
自由现金流更多
FGI
多$50.0M
$-47.7M
两年增速更快
FGI
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.4M | $30.5M |
| 净利润 | — | $-2.6M |
| 毛利率 | — | 26.7% |
| 营业利润率 | -211.9% | -2.2% |
| 净利率 | — | -8.6% |
| 营收同比 | -23.8% | -14.4% |
| 净利润同比 | — | -553.1% |
| 每股收益（稀释后） | $-1.41 | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DNAFGI
| Q4 25 | $33.4M | $30.5M | ||
| Q3 25 | $38.8M | $35.8M | ||
| Q2 25 | $49.6M | $31.0M | ||
| Q1 25 | $48.3M | $33.2M | ||
| Q4 24 | $43.8M | $35.6M | ||
| Q3 24 | $89.0M | $36.1M | ||
| Q2 24 | $56.2M | $29.4M | ||
| Q1 24 | $37.9M | $30.8M |
净利润DNAFGI
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-80.8M | $-1.7M | ||
| Q2 25 | $-60.3M | $-1.2M | ||
| Q1 25 | $-91.0M | $-629.1K | ||
| Q4 24 | — | $-402.3K | ||
| Q3 24 | $-56.4M | $-550.1K | ||
| Q2 24 | $-217.2M | $163.6K | ||
| Q1 24 | $-165.9M | $-412.2K |
毛利率DNAFGI
| Q4 25 | — | 26.7% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 28.1% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 27.4% |
营业利润率DNAFGI
| Q4 25 | -211.9% | -2.2% | ||
| Q3 25 | -231.8% | 1.0% | ||
| Q2 25 | -132.1% | -2.7% | ||
| Q1 25 | -184.1% | -3.9% | ||
| Q4 24 | -236.3% | -3.5% | ||
| Q3 24 | -62.0% | -0.2% | ||
| Q2 24 | -396.7% | -1.5% | ||
| Q1 24 | -469.1% | -1.0% |
净利率DNAFGI
| Q4 25 | — | -8.6% | ||
| Q3 25 | -207.9% | -4.6% | ||
| Q2 25 | -121.6% | -4.0% | ||
| Q1 25 | -188.2% | -1.9% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | -63.3% | -1.5% | ||
| Q2 24 | -386.4% | 0.6% | ||
| Q1 24 | -437.3% | -1.3% |
每股收益（稀释后）DNAFGI
| Q4 25 | $-1.41 | $-1.63 | ||
| Q3 25 | $-1.45 | $-0.86 | ||
| Q2 25 | $-1.10 | $-0.64 | ||
| Q1 25 | $-1.68 | $-0.07 | ||
| Q4 24 | $-1.91 | $-0.38 | ||
| Q3 24 | $-1.08 | $-0.29 | ||
| Q2 24 | $-4.23 | $0.08 | ||
| Q1 24 | $-3.32 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $422.6M | $1.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $508.6M | $17.3M |
| 总资产 | $1.1B | $69.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DNAFGI
| Q4 25 | $422.6M | $1.9M | ||
| Q3 25 | $495.5M | $1.9M | ||
| Q2 25 | $559.4M | $2.5M | ||
| Q1 25 | $325.3M | $1.2M | ||
| Q4 24 | $561.6M | $4.6M | ||
| Q3 24 | $616.2M | $3.0M | ||
| Q2 24 | $730.4M | $1.3M | ||
| Q1 24 | $840.4M | $3.3M |
股东权益DNAFGI
| Q4 25 | $508.6M | $17.3M | ||
| Q3 25 | $559.8M | $19.7M | ||
| Q2 25 | $613.0M | $21.3M | ||
| Q1 25 | $647.4M | $21.8M | ||
| Q4 24 | $716.1M | $22.3M | ||
| Q3 24 | $797.9M | $23.5M | ||
| Q2 24 | $833.1M | $23.8M | ||
| Q1 24 | $987.3M | $23.9M |
总资产DNAFGI
| Q4 25 | $1.1B | $69.5M | ||
| Q3 25 | $1.2B | $73.0M | ||
| Q2 25 | $1.2B | $71.7M | ||
| Q1 25 | $1.3B | $68.5M | ||
| Q4 24 | $1.4B | $75.5M | ||
| Q3 24 | $1.5B | $74.7M | ||
| Q2 24 | $1.6B | $69.9M | ||
| Q1 24 | $1.6B | $68.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-47.7M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $-47.7M | $2.3M |
| 自由现金流率自由现金流/营收 | -142.8% | 7.5% |
| 资本支出强度资本支出/营收 | 0.0% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-212.5K |
8季度趋势，按日历期对齐
经营现金流DNAFGI
| Q4 25 | $-47.7M | $2.3M | ||
| Q3 25 | $-31.6M | $-1.9M | ||
| Q2 25 | $-40.3M | $7.6M | ||
| Q1 25 | $-51.5M | $-7.4M | ||
| Q4 24 | $-42.4M | $617.4K | ||
| Q3 24 | $-103.5M | $-915.0K | ||
| Q2 24 | $-84.4M | $862.1K | ||
| Q1 24 | $-89.3M | $-8.0M |
自由现金流DNAFGI
| Q4 25 | $-47.7M | $2.3M | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | $-40.3M | $7.4M | ||
| Q1 25 | $-59.1M | $-7.7M | ||
| Q4 24 | $-56.1M | $-214.1K | ||
| Q3 24 | $-118.6M | $-1.1M | ||
| Q2 24 | $-111.4M | $281.5K | ||
| Q1 24 | $-96.0M | $-8.6M |
自由现金流率DNAFGI
| Q4 25 | -142.8% | 7.5% | ||
| Q3 25 | — | -5.9% | ||
| Q2 25 | -81.2% | 23.8% | ||
| Q1 25 | -122.4% | -23.3% | ||
| Q4 24 | -128.0% | -0.6% | ||
| Q3 24 | -133.2% | -3.0% | ||
| Q2 24 | -198.2% | 1.0% | ||
| Q1 24 | -252.9% | -28.0% |
资本支出强度DNAFGI
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 15.8% | 1.1% | ||
| Q4 24 | 31.3% | 2.3% | ||
| Q3 24 | 16.9% | 0.5% | ||
| Q2 24 | 48.1% | 2.0% | ||
| Q1 24 | 17.7% | 2.0% |
现金转化率DNAFGI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.27× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DNA
| Cell Engineering Segment | $26.0M | 78% |
| Other | $7.4M | 22% |
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
